Tissue Regenix Group (LSE:TRX) EBIT per Share : £-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group EBIT per Share?

Tissue Regenix Group's EBIT per Share for the six months ended in Dec. 2023 was £-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 64.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 64.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 40.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tissue Regenix Group's EBIT per Share or its related term are showing as below:

LSE:TRX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -85.3 Med: -0.9 Max: 66.5
Current: 64.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Tissue Regenix Group was 66.50% per year. The lowest was -85.30% per year. And the median was -0.90% per year.

LSE:TRX's 3-Year EBIT Growth Rate is ranked better than
96.63% of 1304 companies
in the Biotechnology industry
Industry Median: 3.6 vs LSE:TRX: 64.60

Tissue Regenix Group's EBIT for the six months ended in Dec. 2023 was £-0.25 Mil.

Tissue Regenix Group EBIT per Share Historical Data

The historical data trend for Tissue Regenix Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group EBIT per Share Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.61

-0.21

-0.05

-0.02

-0.01

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.01	-0.01	-	-

Tissue Regenix Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tissue Regenix Group's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.419	/	70.427
=	-0.01

Tissue Regenix Group's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.247	/	70.496
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.01

Tissue Regenix Group (LSE:TRX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tissue Regenix Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.